The ESCP Safe-anastomosis Programme in Colorectal Surgery (EAGLE) is an international, cluster randomised-sequence study of a Safe-anastomosis Quality Improvement Intervention to reduce anastomotic leak following right colectomy and ileocaecal resection.
Anastomotic leak is a severe, potentially life-threatening complication following right colectomy. Internationally, anastomotic leak occurs after 8% of right colectomies. Prospective cohort data demonstrate that patient selection, intraoperative factors, and technical variation are risk factors for anastomotic leak.
The Eagle trial is the latest and most ambitious of the global ‘snap shot studies’ that the European Society of Coloproctology (ESCP) has run over the past five years. The study consists of interactive, online training modules for surgeons and theatre teams and will assess whether implementation of the ESCP Safe-anastomosis intervention reduces risk of anastomotic leak rate.
Overall, we are aiming to collaborate with more than 2,000 surgeons in over 300 hospitals across the world, including 4,500 patients in total.
You can find out more about EAGLE, including how to get involved at https://is.gd/EAGLEsitesetup
EAGLE will collaborate with researchers in high, middle and low income countries all around the world. Hospitals across Europe, South East Asia, South America, the USA, Saudi Arabia, North Africa and Russia have already registered to participate.
EAGLE is funded by the European Society of Coloproctology and supported by the University of Birmingham Clinical Trials Unit and the NIHR Global Health Research Unit on Global Surgery